コンテンツへスキップ
Merck
  • Salivary biomarkers, vital signs and behaviour of pre-school children during their first dental visit.

Salivary biomarkers, vital signs and behaviour of pre-school children during their first dental visit.

European journal of paediatric dentistry : official journal of European Academy of Paediatric Dentistry (2013-12-10)
S S Rodrigues Gomes, A C Barretobezerra, A C Maia Prado
要旨

Anxiety may influence dental treatment unfavourably, thus evaluation of the psychophysiological reactions of the child may reduce its negative effects. This study aimed to evaluate and correlate the levels of cortisol and alpha-amylase, vital signs and behaviour of children during their first dental visit. Study sample consisted of 32 children (11 male and 21 female patients) aged between 4 and 6 years, who would go to the dentist for the first time, with no pain or chronic illness, and without the use of medication. Three saliva samples were collected: before, immediately after and 20 minutes after the dental procedure (dental prophylaxis). Data were analysed using Student's t test and Pearson's correlation test (p = 0.05). In the comparison of the levels of alpha-amylase, the heart rate and blood pressure were higher after the dental visit and the levels of salivary cortisol were significantly higher before. There was no statistically significant difference in the correlation between the Frankl Behaviour Rating Scale and the levels of cortisol and alpha-amylase, but the results showed that the levels of these two salivary biomarkers increased gradually as the child had a less cooperative behaviour. CONCLUSION The sample revealed that the first dental visit generated anxiety, which was manifested through physiological and behavioural alterations.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
α-アミラーゼ, 熱安定型, solution, for use in Total Dietary Fiber Assay, TDF-100A
Sigma-Aldrich
ヒドロコルチゾン, BioReagent, suitable for cell culture
Sigma-Aldrich
ヒドロコルチゾン 溶液, 50 μM, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
α-アミラーゼ from human saliva, Type XIII-A, lyophilized powder, 300-1,500 units/mg protein
Sigma-Aldrich
ヒドロコルチゾン, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
α-アミラーゼ ブタ膵臓由来, Type VI-B, ≥5 units/mg solid
Sigma-Aldrich
ヒドロコルチゾン, ≥98% (HPLC)
Sigma-Aldrich
タカジアスターゼ from Aspergillus oryzae, powder, slightly beige, ~100 U/mg
Sigma-Aldrich
α-アミラーゼ from Aspergillus oryzae, powder, ~30 U/mg
Sigma-Aldrich
α-アミラーゼ Bacillus licheniformis由来, Type XII-A, saline solution, ≥500 units/mg protein (biuret)
Sigma-Aldrich
α-アミラーゼ Bacillus sp.(バシラス属)由来, Type II-A, lyophilized powder, ≥1,500 units/mg protein (biuret)
Supelco
コルチゾール 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
α-アミラーゼ from Aspergillus oryzae, ≥150 units/mg protein (biuret)
Sigma-Aldrich
α-アミラーゼ Bacillus licheniformis由来, lyophilized powder, 500-1,500 units/mg protein, 93-100% (SDS-PAGE)
Sigma-Aldrich
α-アミラーゼ from human saliva, Type IX-A, lyophilized powder, 1,000-3,000 units/mg protein
Sigma-Aldrich
α-アミラーゼ Bacillus subtilis(枯草菌)由来, powder, yellow-brown, ~50 U/mg
Sigma-Aldrich
α-アミラーゼ from Aspergillus oryzae, powder, ~1.5 U/mg (~0.2 U acc. to Willstätter)
Sigma-Aldrich
α-アミラーゼ Bacillus sp.(バシラス属)由来, liquid
Sigma-Aldrich
α-アミラーゼ ブタ膵臓由来, PMSF Treated, Type I-A, saline suspension, ≥1000 units/mg protein (E1%/280)
Sigma-Aldrich
α-アミラーゼ Bacillus sp.(バシラス属)由来, powder, ≥400 units/mg protein (Lowry)
Sigma-Aldrich
α-アミラーゼ from Aspergillus oryzae, aqueous solution, ≥800 FAU/g
Sigma-Aldrich
α-アミラーゼ Bacillus amyloliquefaciens由来, liquid, ≥250 units/g
Sigma-Aldrich
α-アミラーゼ Bacillus subtilis(枯草菌)由来, powder, yellow-brown, ~380 U/mg
Sigma-Aldrich
α-アミラーゼ ブタ膵臓由来, Type I-A, PMSF treated, saline suspension, 700-1400 units/mg protein (E1%/280)
Sigma-Aldrich
ヒドロコルチゾン, meets USP testing specifications
Supelco
ヒドロコルチゾン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
α-アミラーゼ Bacillus licheniformis由来, suitable for determination of starch (Kit STA-20)